De-Intensification Of Blood Glucose Lowering Medication In People Identified As Being Over-Treated: A Mixed Methods Study

References

• UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–853.9742976
   PubMed Web of Science ®Google Scholar
• Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–1589. doi:10.1056/NEJMoa080647018784090
   PubMed Web of Science ®Google Scholar
• Geller AI, Shehab N, Lovegrove MC, et al. National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations. JAMA Intern Med. 2014;174(5):678–686. doi:10.1001/jamainternmed.2014.13624615164
   PubMed Web of Science ®Google Scholar
• Signorovitch JE, Macaulay D, Diener M, et al. Hypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non-insulin antidiabetes drugs. Diabetes Obes Metab. 2013;15(4):335–341. doi:10.1111/dom.1203123121373
   PubMed Web of Science ®Google Scholar
• Zaccardi F, Davies MJ, Dhalwani NN, et al. Trends in hospital admissions for hypoglycaemia in England: a retrospective, observational study. Lancet Diabetes Endocrinol. 2016;4(8):677–685. doi:10.1016/S2213-8587(16)30091-227293218
   PubMed Web of Science ®Google Scholar
• Majumdar SR, Hemmelgarn BR, Lin M, McBrien K, Manns BJ, Tonelli M. Hypoglycemia associated with hospitalization and adverse events in older people. Diabetes Care. 2013;36(11):3585LP–3590. doi:10.2337/dc13-052324089536
   PubMed Web of Science ®Google Scholar
• Zoungas S, Patel A, Chalmers J, et al. Severe hypoglycemia and risks of vascular events and death. N Engl J Med. 2010;363(15):1410–1418. doi:10.1056/NEJMoa100379520925543
   PubMed Web of Science ®Google Scholar
• Fitzpatrick C, Chatterjee S, Seidu S, et al. Association of hypoglycaemia and risk of cardiac arrhythmia in patients with diabetes mellitus: a systematic review and meta-analysis. Diabetes Obes Metab. 2018;20(9):2169–2178. doi:10.1111/dom.1334829740922
   PubMed Web of Science ®Google Scholar
• Bonds DE, Miller ME, Bergenstal RM, et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. Bmj. 2010;340:b4909. doi:10.1136/bmj.b490920061358
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 11. Older adults. Diabetes Care. 2017;40(Suppl1):S99–S104. doi:10.2337/dc17-S01427979898
   PubMedGoogle Scholar
• Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2012;55(6):1577–1596. doi:10.1007/s00125-012-2534-022526604
   PubMed Web of Science ®Google Scholar
• Rutten GEHM, de Grauw WJC, Nijpels G, et al. NHG-standaard diabetes mellitus type 2 (derde herziening). Huisarts Wet. 2013;56(10):512–525.
   Google Scholar
• Arnold SV, Lipska KJ, Wang J, Seman L, Mehta SN, Kosiborod M. Use of intensive glycemic management in older adults with diabetes mellitus. J Am Geriatr Soc. 2018. doi:10.1111/jgs.15335
   Web of Science ®Google Scholar
• Maciejewski ML, Mi X, Sussman J, et al. Overtreatment and deintensification of diabetic therapy among medicare beneficiaries. J Gen Intern Med. 2018;33(1):34–41. doi:10.1007/s11606-017-4167-y28905179
   PubMed Web of Science ®Google Scholar
• Hambling CE, Seidu S, Davies MJ, Khunti K. Older people with type 2 diabetes, including those with chronic kidney disease or dementia, are commonly overtreated with sulfonylurea or insulin therapies. Diabet Med. 2017. doi:10.1111/dme.13380
   Web of Science ®Google Scholar
• Dejager S, Penfornis A, Fiquet B, Blickle JF. Potential glycemic overtreatment in patients ≥75 years with type 2 diabetes mellitus and renal disease: experience from the observational OREDIA study. Diabetes Metab Syndr Obes Targets Ther. 2015;8:303. doi:10.2147/DMSO.S83897
   Web of Science ®Google Scholar
• Lipska KJ, Ross JS, Miao Y, Shah ND, Lee SJ, Steinman MA. Potential overtreatment of diabetes mellitus in older adults with tight glycemic control. JAMA Intern Med. 2015;175(3):356–362. doi:10.1001/jamainternmed.2014.734525581565
   PubMed Web of Science ®Google Scholar
• Andreassen LM, Sandberg S, Kristensen GBB, UØ S, Kjome RLS. Nursing home patients with diabetes: prevalence, drug treatment and glycemic control. Diabetes Res Clin Pract. 2014;105(1):102–109. doi:10.1016/j.diabres.2014.04.01224853809
   PubMed Web of Science ®Google Scholar
• Müller N, Khunti K, Kuss O, et al. Is there evidence of potential overtreatment of glycaemia in elderly people with type 2 diabetes? Data from the GUIDANCE study. Acta Diabetol. 2017;54(2):209–214. doi:10.1007/s00592-016-0939-927837286
   PubMed Web of Science ®Google Scholar
• Khunti K, Davies MJ. Clinical inertia-time to reappraise the terminology?. Prim Care Diabetes. 2017;11(2):105–106. doi:10.1016/j.pcd.2017.01.00728222959
   PubMed Web of Science ®Google Scholar
• Davies MJ, D’Alessio DA, Fradkin J, et al. Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018:dci180033. doi:10.2337/dci18-0033
   Web of Science ®Google Scholar
• Rutten GEHM, Alzaid A. Person-centred type 2 diabetes care: time for a paradigm shift. Lancet Diabetes Endocrinol. 2018;6(4):264–266. doi:10.1016/S2213-8587(17)30193-628606729
   PubMed Web of Science ®Google Scholar
• Hart HE, Rutten GE, Bontje KN, Vos RC. Overtreatment of older patients with type 2 diabetes mellitus in primary care. Diabetes Obes Metab. 2018;20(4):1066–1069. doi:10.1111/dom.1317429193555
   PubMed Web of Science ®Google Scholar
• Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47(6):555–567. doi:10.1016/S0022-3999(99)00057-410661603
   PubMed Web of Science ®Google Scholar
• Sussman JB, Kerr EA, Saini SD, et al. Rates of deintensification of blood pressure and glycemic medication treatment based on levels of control and life expectancy in older patients with diabetes mellitus. JAMA Intern Med. 2015;175(12):1942–1949. doi:10.1001/jamainternmed.2015.511026502220
   PubMed Web of Science ®Google Scholar
• Vimalananda VG, DeSotto K, Chen T, et al. A quality improvement program to reduce potential overtreatment of diabetes among veterans at high risk of hypoglycemia. Diabetes Spectr. 2017;30(3):211–216. doi:10.2337/ds16-000628848316
   PubMedGoogle Scholar
• Lipska KJ, Krumholz H, Soones T, Lee SJ. Polypharmacy in the aging patient: a review of glycemic control in older adults with type 2 diabetes. JAMA. 2016;315(10):1034–1045. doi:10.1001/jama.2016.029926954412
   PubMed Web of Science ®Google Scholar
• Formiga F, Vidal X, Agusti A, et al. Inappropriate prescribing in elderly people with diabetes admitted to hospital. Diabet Med. 2016;33(5):655–662. doi:10.1111/dme.1289426333026
   PubMed Web of Science ®Google Scholar
• Reach G, Pechtner V, Gentilella R, Corcos A, Ceriello A. Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitusitle. Diabetes Metab. 2017;43(6):501–511. doi:10.1016/j.diabet.2017.06.00328754263
   PubMed Web of Science ®Google Scholar
• Crowley MJ, Smith VA, Olsen MK, Danus S, Oddone EZ, Bosworth HBPB. Treatment intensification in a hypertension telemangement trial. Clinical inertia or good clinical judgment. Hypertension. 2011;58(4):552–558. doi:10.1161/HYPERTENSIONAHA.111.17436721844490
   PubMed Web of Science ®Google Scholar
• Persell SD, Dolan NC, Friesema EM, Thompson JA, Kaiser DBD. Frequency of inappropriate medical exceptions to quality measures. Ann Intern Med. 2010;152(4):225–231. doi:10.7326/0003-4819-152-4-201002160-0000720157137
   PubMed Web of Science ®Google Scholar
• Safford M, Shewchuk R, Williams JH, Estrada CA, Ovalle FAJ. Reasons for not intensifying medications: differentiating “clinical inertia” from appropriate care. J Gen Intern Med. 2007;22(12):1648–1655. doi:10.1007/s11606-007-0433-817957346
   PubMed Web of Science ®Google Scholar
• Caverly TJ, Fagerlin A, Zikmund-Fisher BJ, et al. Appropriate prescribing for patients with diabetes at high risk for hypoglycemia. JAMA Intern Med. 2015;175(12):1994. doi:10.1001/jamainternmed.2015.595026502113
   PubMed Web of Science ®Google Scholar
• von Arx L-B, Kjær T. The patient perspective of diabetes care: a systematic review of stated preference research. Patient Patient Centered Outcomes Res. 2014;7(3):283–300. doi:10.1007/s40271-014-0057-0
   Web of Science ®Google Scholar
• Svedbo Engström M, Leksell J, Johansson U-B, Gudbjörnsdottir S. What is important for you? A qualitative interview study of living with diabetes and experiences of diabetes care to establish a basis for a tailored patient-reported outcome measure for the Swedish National Diabetes Register. BMJ Open. 2016;6(3):e010249. doi:10.1136/bmjopen-2015-010249
   Web of Science ®Google Scholar